Dr Reddy's Q4 Preview: PAT may rise over 50% YoY on strong U

According to an average estimate of four brokerages, revenue from operations in the January-March 2023 period is seen growing up to 18% year-on-year. Meanwhile, net profit after tax is likely to surge up to 54% YoY.

Related Keywords

India , Russia , United States , American , Motilal Oswal , , North American , Dr Reddy S , Dr Reddys Laboratories , Q4 Preview , Pat , Bus Sales , Pharma Major , Revenue Growth , Net Profit , Generic Industry , Consolidated Net Profit , Us Generic Industry Dynamics , Dr Reddys Q4 Preview , Dr Reddys Q4 , Dr Reddys Q4 Results , Drl Q4 , Drl Q4 Results , Kotak Equities , Nuvama ,